Shatterproof
Registered Principal Details
Business Or Interest:
The organization is supported by those wishing to end the evils of addiction.
Lobbying Interests:
Shatterproof will work to educate, empower and equip parents, families, educators, health care providers, legislators, and others to address addiction head on. Specific attention will be paid to PDMP legislation.
The organization is supported by those wishing to end the evils of addiction.
Lobbying Interests:
Shatterproof will work to educate, empower and equip parents, families, educators, health care providers, legislators, and others to address addiction head on. Specific attention will be paid to PDMP legislation.
Contact
TP
Tim Plunkett
1221 Ave of the Americas
New York, NY 10020
(212) 905-8317
timothy.plunkett@dentons.com
1221 Ave of the Americas
New York, NY 10020
(212) 905-8317
timothy.plunkett@dentons.com
Authorized Lobbyists
Lobbyist Name | Exclusive Duties | Authorized On | Withdrawn On |
---|---|---|---|
Joe K Leibham | Exclusive Duties N/A | Authorized On 11/5/2015 | Withdrawn On N/A |
Jason Childress | Exclusive Duties N/A | Authorized On 11/5/2015 | Withdrawn On N/A |
Wendy Coomer | Exclusive Duties N/A | Authorized On 11/5/2015 | Withdrawn On N/A |
Lobbying Interests
Legislative Bills/Resolutions
Assembly Bill 766
Relating to: review and reporting requirements for the Prescription Drug Monitoring Program. (FE)
Bill Text and History
2015 Wisconsin Act 267
1/26/2016
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: review and reporting requirements for the Prescription Drug Monitoring Program. (FE)
Bill Text and History
2015 Wisconsin Act 267
For
Notification Date1/26/2016
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Senate Bill 716
Relating to: review and reporting requirements for the Prescription Drug Monitoring Program. (FE)
Bill Text and History
2/10/2016
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: review and reporting requirements for the Prescription Drug Monitoring Program. (FE)
Bill Text and History
For
Notification Date2/10/2016
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Topics Not Yet Assigned A Bill Or Rule Number
Development, drafting or introduction of a proposal relating to
Legislation and rules concerning the Prescription Drug Monitoring Program
Legislation and rules concerning the Prescription Drug Monitoring Program
Action Intended To Affect
Both Legislative matter and rule
Notification Date
1/4/2016
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Both Legislative matter and rule
Notification Date
1/4/2016
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Total Lobbying Effort
2015 July - December |
2016 January - June |
2016 July - December |
Total | |
---|---|---|---|---|
Total Lobbying Expenditures | 2015 July - December $13,849.00 |
2016 January - June $13,000.00 |
2016 July - December $0.00 |
Total $26,849.00 |
Total Hours Communicating | 2015 July - December 9.00 |
2016 January - June 2.20 |
2016 July - December 0.00 |
Total 11.20 |
Total Hours Other | 2015 July - December 34.60 |
2016 January - June 12.80 |
2016 July - December 0.00 |
Total 47.40 |
Percent Allocation of Lobbying Effort
Legislative Bills/Resolutions
Relating to: review and reporting requirements for the Prescription Drug Monitoring Program. (FE)
2015 January - June |
2015 July - December |
2016 January - June |
2016 July - December |
Total |
---|---|---|---|---|
2015 January - June |
2015 July - December 50% |
2016 January - June 50% |
2016 July - December |
Total 51% |
Budget Bill Subjects
No budget bill subjects found.
Administrative Rulemaking Proceedings
No administrative rulemaking proceedings found.
Topics Not Yet Assigned A Bill Or Rule Number
2015 January - June |
2015 July - December |
2016 January - June |
2016 July - December |
Total |
---|---|---|---|---|
2015 January - June |
2015 July - December 50% |
2016 January - June 50% |
2016 July - December |
Total 50% |
Minor Efforts
No minor efforts found.
Other Matters
Includes time spent on:
- Gubernatorial nominations
- Matters on which the organization made no lobbying communication